These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4427418)

  • 1. Reduced in vitro binding of tryptophan by plasma in uremia.
    de Torrente A; Glazer GB; Gulyassy P
    Kidney Int; 1974 Oct; 6(4):222-9. PubMed ID: 4427418
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein binding of diazepam and digitoxin in uremic and normal serum.
    Kober A; Sjöholm I; Borgå O; Odar-Cederlöf I
    Biochem Pharmacol; 1979 Apr; 28(7):1037-42. PubMed ID: 444260
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin.
    Mingrone G; De Smet R; Greco AV; Bertuzzi A; Gandolfi A; Ringoir S; Vanholder R
    Clin Chim Acta; 1997 Apr; 260(1):27-34. PubMed ID: 9101098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of plasma albumin in relation to decreased drug binding in uremia.
    Boobis SW
    Clin Pharmacol Ther; 1977 Aug; 22(2):147-53. PubMed ID: 407044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.
    Verbeeck RK; De Schepper PJ
    Clin Pharmacol Ther; 1980 May; 27(5):628-35. PubMed ID: 7371361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
    Olsen GD; Bennett WM; Porter GA
    Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis and plasma amino acid composition in chronic renal failure.
    Gulyassy PF; Peters JH; Lin SC; Ryan PM
    Am J Clin Nutr; 1968 Jun; 21(6):565-73. PubMed ID: 5666633
    [No Abstract]   [Full Text] [Related]  

  • 9. Folic acid, hypersegmented polymorphonuclear leukocytes and the uremic syndrome.
    Siddiqui J; Freeburger R; Freeman RM
    Am J Clin Nutr; 1970 Jan; 23(1):11-6. PubMed ID: 5412645
    [No Abstract]   [Full Text] [Related]  

  • 10. Tryptophan and indolic tryptophan metabolites in chronic renal failure.
    Saito A; Niwa T; Maeda K; Kobayashi K; Yamamoto Y; Ohta K
    Am J Clin Nutr; 1980 Jul; 33(7):1402-6. PubMed ID: 7395768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of albumin-binding ligands present in uremic serum by high-performance affinity chromatography.
    Mabuchi H; Nakahashi H
    J Chromatogr; 1990 Aug; 529(2):424-30. PubMed ID: 2229260
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma protein binding in uremia: extraction and characterization of an inhibitor.
    Depner TA; Gulyassy PF
    Kidney Int; 1980 Jul; 18(1):86-94. PubMed ID: 7218662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid: binding levels of urate ions in normal and uraemic plasma, and in human serum albumin.
    Farrell PC; Ward RA; Hone PW
    Biochem Pharmacol; 1975 Oct; 24(20):1885-7. PubMed ID: 1191338
    [No Abstract]   [Full Text] [Related]  

  • 14. The alteration of plasma proteins in uremia as reflected in the ability to bind diphenylhydantoin.
    Shoeman DW; Benjamin DM; Azarnoff DL
    Ann N Y Acad Sci; 1973 Nov; 226():127-30. PubMed ID: 4520391
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma protein carbonylation in chronic uremia.
    Pavone B; Sirolli V; Giardinelli A; Bucci S; Forlì F; Di Cesare M; Sacchetta P; Di Pietro N; Pandolfi A; Urbani A; Bonomini M
    J Nephrol; 2011; 24(4):453-64. PubMed ID: 21607919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tryptophan, 5-hydroxy indole-3-acetic acid and their protein binding in uremic patients.
    Qureshi GA; Baig SM
    Biochem Mol Biol Int; 1993 Mar; 29(3):411-9. PubMed ID: 7683549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma protein binding of zolpidem in liver and renal insufficiency.
    Pacifici GM; Viani A; Rizzo G; Carrai M; Ganansia J; Bianchetti G; Morselli PL
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):439-43. PubMed ID: 3198298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of human serum albumin in renal failure on conservative and dialysis therapy.
    Bianchi R; Mariani G; Toni MG; Carmassi F
    Am J Clin Nutr; 1978 Sep; 31(9):1615-26. PubMed ID: 685877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia.
    Mabuchi H; Nakahashi H
    Clin Chim Acta; 1987 Jul; 167(1):89-96. PubMed ID: 3665090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin is the major plasma protein target of oxidant stress in uremia.
    Himmelfarb J; McMonagle E
    Kidney Int; 2001 Jul; 60(1):358-63. PubMed ID: 11422772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.